Drug delivery device having dose indicator
A drug delivery device includes a housing defining a shell having a proximal end and a distal end and a longitudinal axis extending between the proximal end and the distal end, a needle assembly at least partially disposed within the housing at the proximal end, a drive assembly at least partially disposed within the housing and operably coupled to the needle assembly, and an audible indicator operably coupled to the drive assembly. The needle assembly includes a syringe containing a medicament and a needle or a cannula. The drive assembly is movable between an initial position and a second position that results in the medicament being expelled from the syringe. Upon the drive assembly being positioned in the second position, the audible indicator engages the drive assembly to generate an audible sound indicating the medicament has been expelled from the syringe.
1. A drug delivery device comprising:
a housing defining a shell having a proximal end and a distal end and a longitudinal axis extending between the proximal end and the distal end thereof;
a needle assembly at least partially disposed within the housing at the proximal end thereof, the needle assembly comprising a syringe containing a medicament and a needle or a cannula;
a drive assembly at least partially disposed within the housing and operably coupled to the needle assembly, the drive assembly including a plunger rod and a plunger rod guide, the plunger rod having a first end and a second end, the drive assembly being movable between an initial position and a second position that results in the medicament being expelled from the syringe; and
an audible indicator operably coupled to the drive assembly, the audible indicator comprising a ring having an engagement tab, the ring including at least one winged portion that at least partially surrounds the plunger rod guide such that upon the drive assembly being positioned in the second position, the audible indicator engages the second end of the plunger rod to generate an audible sound indicating the medicament has been expelled from the syringe.
2. The drug delivery device of claim 1 , wherein the audible indicator is adapted to at least partially disengage from the drive assembly upon commencement of movement of the drive assembly from the initial position towards the second position.
3. The drug delivery device of claim 1 , wherein the plunger rod further comprises a first detent positioned at the second end.
4. The drug delivery device of claim 3 , wherein the plunger rod further comprises a second detent positioned at a distance between the first end and the second end.
5. The drug delivery device of claim 1 , wherein the audible indicator is constructed from at least one of a polymer or a metallic material.
6. The drug delivery device of claim 1 , wherein the audible indicator is in a relaxed configuration when the drive assembly is in the second position.
7. The drug delivery device of claim 1 , wherein the audible indicator is in a relaxed configuration when the drive assembly is in the initial position.
8. A drug delivery device comprising:
a housing defining a shell having a proximal end and a distal end and a longitudinal axis extending between the proximal end and the distal end thereof;
a needle assembly at least partially disposed within the housing at the proximal end thereof, the needle assembly comprising a syringe containing a medicament and a needle or a cannula;
a drive assembly at least partially disposed within the housing and operably coupled to the needle assembly, the drive assembly including a plunger rod having a first end including a magnetic member, the drive assembly being movable between an initial position and a second position that results in the medicament being expelled from the syringe; and
an audible indicator operably coupled to the drive assembly, the audible indicator including a metallic member such that upon completion of delivery of the medicament via the needle assembly, the metallic member of the audible indicator engages the magnetic member of the plunger rod to generate an audible sound indicating the medicament has been expelled from the syringe.
9. The drug delivery device of claim 8 , wherein the audible indicator is constructed from at least one of a polymer or a metallic material.
10. The drug delivery device of claim 8 , wherein the audible indicator is in a relaxed configuration when the drive assembly is in the second position.
11. The drug delivery device of claim 8 , wherein the audible indicator is in a relaxed configuration when the drive assembly is in the initial position.
12. The drug delivery device of claim 1 , wherein the syringe is filled or pre-filled with the medicament, and wherein the medicament comprises evolocumab.
13. The drug delivery device of claim 8 , wherein the syringe is filled or pre-filled with the medicament, and wherein the medicament comprises evolocumab.
14. A drug delivery device comprising:
a housing defining a shell having a proximal end and a distal end and a longitudinal axis extending between the proximal end and the distal end thereof;
a needle assembly at least partially disposed within the housing at the proximal end thereof, the needle assembly comprising a syringe containing a medicament and a needle or a cannula;
a drive assembly at least partially disposed within the housing and operably coupled to the needle assembly, the drive assembly including a plunger rod and a plunger rod guide, the plunger rod having a first end and a second end, the drive assembly being movable between an initial position and a second position that results in the medicament being expelled from the syringe; and
an audible indicator operably coupled to the drive assembly, the audible indicator comprising a resilient ring having an engagement tab,
wherein, upon the drive assembly being positioned in the second position, the audible indicator engages the second end of the plunger rod to generate an audible sound indicating the medicament has been expelled from the syringe.
15. The drug delivery device of claim 14 , wherein the syringe is filled or pre-filled with the medicament, and wherein the medicament comprises evolocumab.